AstraZeneca reports disappointing Phase 3 data for lung cancer ADC (NASDAQ:AZN)09/10/2024 IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Phase 3 examine of their antibody drug conjugate, or ADC, datopotamab deruxtecan didn’t present it…
